Aladdin Outdoors

Avigra successor viagra

The Pfizer launched a more affordable version of Viagra in New Zealand under the name of Avigra.

The blue pill composed of Sildenafil who started and still dominated the market for treatments against erectile dysfunction, facilitating the sex lives of men, will now become more affordable.

With patent expiry Viagra scheduled for the month of June, the market will soon be open to generic drugs. The Pfizer originally treatment Viagra will now sell the same treatment, in New Zealand under a different name, Avigra.

Avigra will provide thousands of New Zealanders patients following treatment Viagra a more affordable option with the Ejaculation Trainer guarantee that they will receive the same quality of treatment laboratories Viagra, the drug against erectile dysfunction as prescribed in New Zealand since its launch in 1998.

"Because Viagra is still under patent in most of the world, launched its generic allows us to guarantee patients the same quality of treatment than that Viagra would bring them to a more competitive price," says Frances Benge, head of care for Pfizer in New Zealand.

So far, the relatively high cost of a treatment against erectile dysfunction has prevented men to relieve themselves of their problem. The suggested retail price for Avigra is about 6 € per stamp (available in packs of 4 or 12), almost half the price of Viagra, therefore making it more accessible to many more men, allowing them to improve the quality of their sex life.

Viagra will remain available in New Zealand at its current price for men who prefer to continue their treatment with the original blue pill.

The active Avigra has helped over 37 million people across 120 countries to find a normal sex life by improving the quality of their erections. Because of this, many men using this treatment have reported increases in their self sexually, esteem for themselves and the satisfaction of sex.